Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Kyntra Bio, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 158 | 5 | 152 | −1 |
| Shares | 67.9M | 188.0K | 70.6M | +2.92M (+4.3%) |
| Value | $816.6M | $2.26M | $746.9M | −$67.4M (−8.3%) |
5 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Kyntra Bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 4,092,000 | $43.2M | 1.11% |
| Jane Street Group, LLC | 414,823 | $4.38M | 0.01% |
| Caption Management, LLC | 325,000 | $3.43M | 0.31% |
| AXA S.A. | 210,700 | $2.22M | 0.01% |
| Bank of Montreal | 106,215 | $1.24M | 0.00% |
| Dynamic Technology Lab Private Ltd | 45,725 | $483.0K | 0.05% |
| Gsa Capital Partners LLP | 39,275 | $415.0K | 0.06% |
| Algert Global LLC | 36,440 | $385.0K | 0.03% |
| Squarepoint Ops LLC | 22,232 | $235.0K | 0.00% |
| Bayesian Capital Management, LP | 17,882 | $189.0K | 0.04% |
| Quantamental Technologies LLC | 12,780 | $135.0K | 0.06% |
| Gotham Asset Management, LLC | 10,750 | $114.0K | 0.00% |
| Lazard Asset Management LLC | 5,632 | $59.0K | 0.00% |
| Quantbot Technologies LP | 3,745 | $39.0K | 0.00% |
| Crewe Advisors LLC | 166 | $2.00K | 0.00% |
| Lindbrook Capital, LLC | 170 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 24 | $0 | 0.00% |
| Dark Forest Capital Management LP | 16 | $0 | 0.00% |
| Bell Investment Advisors, Inc | 25 | $0 | 0.00% |
Sold out (20)
Institutions that held Kyntra Bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Farallon Capital Management, L.L.C. | 364,764 | $4.38M |
| ExodusPoint Capital Management, LP | 111,736 | $1.34M |
| AQR Capital Management LLC | 75,280 | $905.0K |
| Northeast Financial Consultants Inc | 54,699 | $657.0K |
| Walleye Trading LLC | 25,905 | $311.0K |
| Qube Research & Technologies Ltd | 22,640 | $272.0K |
| Franklin Street Advisors Inc | 20,000 | $240.0K |
| Blueshift Asset Management, LLC | 13,811 | $166.0K |
| TrinityPoint Wealth, LLC | 11,189 | $134.0K |
| Cambridge Investment Research Advisors, Inc. | 10,631 | $128.0K |
| Point72 Hong Kong Ltd | 1,402 | $17.0K |
| Aquatic Capital Management LLC | 1,300 | $16.0K |
| TCI Wealth Advisors, Inc. | 494 | $6.00K |
| Captrust Financial Advisors | 427 | $5.00K |
| Bessemer Group Inc | 94 | $1.00K |
| Signaturefd, LLC | 96 | $1.00K |
| Northwestern Mutual Wealth Management Co | 5 | $0 |
| Quadrant Capital Group LLC | 13 | $0 |
| Rockefeller Capital Management L.P. | 37 | $0 |
| IFP Advisors, Inc | 20 | – |
Not filed for Q2 2022 yet (5)
Institutions that held Kyntra Bio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 91,623 | $1.10M |
| Parametric Portfolio Associates LLC | 76,760 | $923.0K |
| Amalgamated Financial Corp. | 13,728 | $165.0K |
| Dixon Hughes Goodman Wealth Advisors LLC | 4,900 | $59.0K |
| Nauset Wealth Management. LLC | 1,000 | $12.0K |